iLLUMA NAD+ Skin Booster (2 vial x 5ml) is a next-generation injectable skin booster formulated to revitalise ageing skin from within by targeting cellular energy and repair pathways. Each treatment uses the dual power of NAD+ (nicotinamide adenine dinucleotide) and NMN (nicotinamide mononucleotide) to mimic the body’s natural regeneration cycle, promoting deep cellular renewal. By fuelling NAD+ production and directly supplementing NAD+, the formula helps optimise mitochondrial function, enhance dermal collagen synthesis, improve dermal thickness and protect against UV-induced and oxidative damage. Enriched with hydrating and barrier-supporting actives such as hyaluronic acid and niacinamide, iLLUMA NAD+ Skin Booster delivers long-lasting hydration, brighter and more even skin tone, and improved elasticity and resilience. Supplied as 2 x 5 ml vials for professional use, it can be administered via injection, microneedling, dermaroller or other advanced techniques according to clinic protocol.
Bnefits
Harnesses the synergistic action of NAD+ and NMN for deep cellular renewal and long-term skin rejuvenation.
Reverses visible signs of ageing by supporting mitochondrial function, cellular repair and dermal regeneration.
Improves dermal thickness and stimulates collagen synthesis for firmer, more resilient skin.
Helps protect against UV-induced and oxidative damage, reducing environmental stress on the skin.
Provides deep hydration and brightening, contributing to a more radiant and even complexion.
Strengthens the skin barrier, improving elasticity, resilience and overall skin health.
Targets ageing cells to restore youthful energy and vitality to the skin over time.
Versatile administration methods (injection, microneedling, dermaroller and more) allow customisation to patient needs and clinic protocols.
Indications
General improvement of overall skin health and quality in the face and other suitable areas selected by the practitioner.
Visible signs of skin ageing such as fine lines, dullness, loss of elasticity and thinning skin.
Skin affected by UV damage and oxidative stress where support for cellular repair and antioxidant defence is desired.
Patients seeking a bio-stimulatory skin booster targeting deeper cellular mechanisms via NAD+ / NMN pathways.
Adjunctive use within professional aesthetic treatment plans aimed at long-term skin rejuvenation and resilience.
Composition
NAD+ (nicotinamide adenine dinucleotide) – coenzyme involved in cellular energy production, mitochondrial function and DNA repair.
NMN (nicotinamide mononucleotide) – NAD+ precursor that fuels endogenous NAD+ synthesis and supports cellular metabolism.
Hyaluronic acid – hydrating active to improve moisture levels, plumpness and skin comfort.
Niacinamide – barrier-supporting and brightening ingredient that helps improve tone, texture and resilience.
Additional excipients and stabilisers suitable for injectable skin booster formulations (full technical ingredient list provided in the official product brochure and pack leaflet).
Formulation
Injectable skin booster solution supplied in multi-dose 5 ml vials.
Dual-active formula combining NAD+ and NMN with hydrating and barrier-supporting actives such as hyaluronic acid and niacinamide.
Designed for intradermal / superficial injection and compatible with other delivery methods such as microneedling and dermaroller according to professional protocol.
Non-crosslinked, fluid solution intended solely for professional aesthetic use.
Packaging
Box containing 2 vials x 5 ml of iLLUMA NAD+ Skin Booster (total 10 ml).
Each glass vial is individually labelled with product name, volume, batch number and expiry date.
Outer packaging branded as iLLUMA NAD+ Skin Booster, indicating professional use only and categorisation as a skin booster.
Accompanying product information and brochure available from distributors in digital (PDF) format.
Usage
For professional use only; treatment must be performed by qualified medical or aesthetic practitioners trained in injectable and/or advanced skin booster techniques.
Take a full medical history, assess skin condition and rule out contraindications; obtain informed consent in line with clinic policy.
Cleanse and disinfect the treatment area thoroughly, maintaining aseptic technique throughout the procedure.
Draw the required volume of iLLUMA NAD+ Skin Booster from the vial into a sterile syringe, expelling any air bubbles before administration.
Administer via an appropriate technique such as micro-injections, nappage, intradermal boluses, microneedling-assisted delivery or dermaroller, following the manufacturer’s guidance and clinic protocols.
Distribute product evenly across the treatment area to support uniform rejuvenation and optimal outcomes.
A treatment course typically consists of several sessions spaced weeks apart, with maintenance sessions determined by the practitioner based on clinical response and patient goals.
After treatment, advise patients to avoid makeup directly on the treated area for the rest of the day, to avoid excessive heat (saunas, steam rooms), intense exercise and direct sun exposure for a period as per clinic guidelines, and to use broad-spectrum sun protection.
Dispose of used needles, syringes and remaining product according to sharps and clinical waste regulations.
Contraindications
Known hypersensitivity or allergy to any component of the formulation (e.g. NAD+, NMN, hyaluronic acid, niacinamide or excipients).
Active skin infections, inflammation, dermatitis or open lesions at the intended treatment site.
History of severe keloid or hypertrophic scarring in the areas to be treated.
Uncontrolled systemic disease, significant autoimmune disorders or coagulation abnormalities unless carefully assessed and cleared by a medical professional.
Pregnancy and breastfeeding, as a precaution due to limited safety data for injectable NAD+ / NMN skin boosters in these populations.
Use in individuals under the age specified by local regulations and clinic policy (commonly under 18 years).
Any additional contraindications or cautions outlined in the official product brochure or by local clinical guidelines for injectable skin boosters.
Adverse Effects
Common injection-related effects such as temporary redness, swelling, bruising, tenderness or mild discomfort at injection or microneedling sites.
Transient dryness, tightness or sensitivity in the treated area shortly after the procedure.
Rare risk of local infection or prolonged inflammatory response if aseptic technique and aftercare are not properly followed.
Possible hypersensitivity or allergic reactions to one or more components of the formulation.
As with any injectable treatment, a very small risk of vascular compromise or unintended tissue injury exists, requiring prompt recognition and management by trained practitioners.
Potential post-inflammatory hyperpigmentation or temporary textural changes, particularly in patients with higher Fitzpatrick skin types or those prone to PIH.
Storage Conditions
Store vials in a cool, dry place at a stable temperature within the range specified in the product information (typically controlled room temperature; avoid extremes of heat or cold).
Keep vials in their original carton to protect from light and contamination until use.
Do not freeze; avoid prolonged exposure to direct sunlight or high temperatures.
Do not use the product after the expiry date printed on the packaging or if the solution appears discoloured or contains particulate matter.
Once opened, use the required amount immediately; discard any unused remainder in accordance with local regulations and do not attempt to re-sterilise.
Duration
Usually administered as a series of sessions spaced over several weeks, followed by periodic maintenance treatments; exact number and frequency of sessions are determined by the practitioner based on protocol, skin status and patient goals.
Onset
Initial improvements in hydration and radiance may be seen within days of treatment, with progressive enhancement of dermal thickness, collagen synthesis, elasticity and overall skin quality developing over subsequent weeks and across a full treatment course.
